Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02592447 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT02592447 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 48 participants.
The verdict
NCT02592447, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a small-scale randomized controlled trial.
Interventions
- OTHER Therapy for Targeted Therapy-related Fatigue (TTF)
- OTHER Wait-List Control Condition (WLC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2015-09-29 |
| Est. Completion | 2021-09-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02592447
The ClinicalTrials.gov registry entry for NCT02592447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Therapy for Targeted Therapy-related Fatigue (TTF) is the first listed.
NCT02592447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02592447 about?
NCT02592447 is a clinical study titled "Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention". The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a smal...
What is the current status of trial NCT02592447?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-09-29. Estimated completion is 2021-09-02.
What interventions are being tested in trial NCT02592447?
The interventions under investigation include: Therapy for Targeted Therapy-related Fatigue (TTF) (OTHER), Wait-List Control Condition (WLC) (OTHER).
Who is sponsoring clinical trial NCT02592447?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.